Schizophreniform Disorders and Psychoses.

These clinical terms are familiar to most people, yet few know precisely what they mean. A psychosis in general terms is understood as a profound disturbance of mental functioning in which the functions of thinking, feeling, perception, affective experience, and action are simultaneously affected and impaired. The result is considerable behavioural disturbances that are no longer comprehensible to those around, as they elude human reason and human empathy and are ultimately no longer intelligible (e.g. delusional content).

Inpatient Treatment · Private Insurance · Government Allowance · Self-Pay

Medically reviewed by: Vivien Müller-Prasse, Specialist in Psychiatry and Psychotherapy
Last updated: 17 April 2026
Reading time: approx. 7 minutes

Mandala for psychoses: fragmented, dissolved pattern — The dissolution of the self

Prevalence0.5–1%

of the total population; men and women are equally affected.

Clinical Conditions

The schizophrenia spectrum.

In psychiatric clinical practice, we most commonly encounter the following conditions: schizophrenic psychoses, schizoaffective disorders, delusional disorders, and organically caused psychoses (e.g. in the context of a neurological condition or substance-induced).

Characteristic of schizophrenia (prevalence approximately 0.5–1 % of the total population; men and women equally affected) are the following symptoms (at least one of the first four and two of the subsequent symptoms):

the experience that one's own thoughts become audible, are inserted from outside, withdrawn, or broadcasted
delusions (e.g. persecutory or referential delusions)
auditory hallucinations in the form of commenting or dialoguing voices
bizarre delusions (e.g. the delusional conviction of being a specific famous person)
persistent hallucinations of any sensory modality
disturbances of formal thinking, such as thought blocking, loosening of associations, tangential speech, or neologisms
catatonic symptoms such as agitation, mutism, stupor
negative symptoms such as affective flattening, poverty of speech, apathy, decreased social performance, alogia, attention disturbance, withdrawal

The course of schizophrenic psychoses may be episodic-remitting, episodic with increasing residual symptoms, or chronically deteriorating. We distinguish several subtypes of schizophrenia in current classification systems: paranoid (the most common worldwide), hebephrenic, catatonic, and undifferentiated.

Differential Diagnosis

Schizotypal and schizoaffective disorders.

Schizotypal disorder is characterised by eccentric behaviour and abnormalities of thinking and mood, without them being clearly assignable as schizophrenic symptoms.

In schizoaffective disorder, depressive and manic illness episodes are found in which schizophrenic symptoms are always simultaneously present (in contrast to bipolar disorder).

Development

How psychoses develop.

To understand the development of schizophrenic psychoses, we use the so-called vulnerability-stress model, which assumes a genetically determined vulnerability upon which, however, psychosocial stressors must act in order for the clinically manifest appearance of the psychotic symptoms to occur. Psychosocial stressors in turn are not only negative events or ongoing everyday burdens, but also positive events (e.g. emotional overstimulation through marriage or other positively charged threshold situations) and an irregular daily rhythm. Ultimately, in the psychotic symptomatology there is a dysbalance in the neurotransmitter system (including dopamine) and a disturbed information processing, which ultimately (as above) produces a profound disturbance of thinking, feeling, affective experience, perception, and action, as well as considerable behavioural disturbances.

Pharmacotherapy

The pharmacological foundation.

Psychopharmacological treatment is (provided no other organic condition is the primary cause) the decisive therapy for psychotic symptoms. Essential to promoting the willingness to take antipsychotic medication — in a person who is already tormented by psychotic symptoms (delusions, anxieties, hallucinations, experiences of being influenced, etc.) — are an anxiety-free therapeutic atmosphere and a supportive space for retreat. The additional administration of anxiolytic, sedating medication generally contributes to the patient being able to engage with inpatient treatment and ultimately experience it as helpful.

The choice of antipsychotic is guided by the specific psychotic symptomatology (positive or negative symptoms) and its severity, as well as the respective side effect profile of the medications.

Continued intake of the antipsychotic medication, at a lower dose than in the acute phase, is also an important prerequisite for protection against a further exacerbation of the psychotic symptoms.

Stabilisation

From symptoms to participation.

After initial stabilisation and response of the psychotic symptoms to medication, we pursue a supportive psychotherapeutic approach that includes comprehensive psychoeducation about the clinical picture, the course of the illness, possible triggers of the psychosis, the pharmacological treatment, and the necessary compliance in long-term therapy. In the further course, the aim is to promote structural capacities in self-awareness, to sensitise to early warning symptoms and to foster future awareness of one's own resilience limits, to promote capacities for inner and outer self-delimitation (social competence training, improvement of problem-solving skills), and accordingly to work towards future daily structure and the development of a viable outpatient care network. Family members are always involved in therapy where the patient gives their consent.

The goal of treatment is, following the acute phase/symptom remission, to promote acceptance of the illness and to impart coping strategies that enable appropriate stability and quality of life, taking into account the dignity of the patient, their need for autonomy, and their existing support needs.

Häufige Fragen

Answers to frequently asked questions about schizophreniform disorders and psychoses.

Patients, relatives, and referring physicians ask us recurring questions. Here you will find the most important answers summarised.

01.Does Sanima Klinik treat acute psychoses?

We treat conditions within the schizophrenia spectrum within the scope of our admission criteria — but not patients with acute risk of harm to themselves or others. Whether treatment at our clinic is appropriate is carefully clarified during the initial telephone consultation.

02.How important is medication in schizophrenic psychoses?

Very important: psychopharmacological treatment is the foundation of therapy — also to protect against further deterioration. The choice of antipsychotic is guided by the respective symptoms and is closely supervised by medical staff.

03.Who covers the cost of treatment?

Admission is open to privately insured patients, those entitled to government allowance (Beihilfe), and self-pay patients. Some statutory health insurers (e.g. Techniker Krankenkasse and DAK) stipulate in their statutes that, under certain conditions, they may cover the costs of treatment at a purely private clinic up to the level of comparable rates at a hospital approved under Section 108 SGB V. We are happy to advise you during the initial telephone consultation.

04.How do I arrange an admission interview?

By telephone on +49 7083 748-0 (Mon–Fri 8:00–16:30) or via the Call-Back Service on the contact page. Our admissions office will respond within 24 hours with a proposed appointment for a detailed, no-obligation telephone consultation.

Quellen

Fachliche Grundlage der Inhalte.

[1]S3 Guideline: Schizophrenia AWMF Guideline Registry (ed.). register.awmf.org — current guidelines
[2]ICD-10-GM — Chapter V, F20–F29 (Schizophrenia, Schizotypal and Delusional Disorders) Federal Institute for Drugs and Medical Devices (BfArM). bfarm.de — ICD-10-GM
[3]German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN) Professional Information. dgppn.de

Admission

Contact us — personally, confidentially, without delay.

Phone · Admissions Office

+49 7083 748-0

Admission

Privately insured · Entitled to supplementary benefits · Self-paying

Patients of some statutory health insurance providers (e.g. Techniker Krankenkasse and DAK) may in certain cases be able to obtain partial cost reimbursement from their insurer.

Request admission consultation → Download clinic brochure